Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of metformin on hepatic free fatty acid metabolism in type 2 diabetes assessed by PET
2012-000808-16Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM) and dyslipidemia, sponsored by Aarhus University Hospital. Primary endpoint: hepatic FFA uptake. Started Mar 2013; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on 2012-000808-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000808-16.